Salesforce, Inc. is rated a Buy supported by its growth outlook and improving operating metrics. Learn more about CRM stock ...
Cloud-computing firm Salesforce was hit with a proposed class action lawsuit by two authors who alleged the company used ...
Salesforce stock has a new bold $60 billion FY30 target, but growth doubts and high valuation persist. See why investors ...
FDA’s Authority Over Lab-Developed Tests Overturned: What the Court’s Decision Means for Lab Testing
Previously, this blog covered the FDA’s decision to regulate lab-developed tests (LDTs) as medical devices. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback